| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd0c7a35edeeb6666108ae63f1acf74c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b760c6a1b7125a20e34e2e0dfa49d7e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_885205936d6b5ebe7e41fe8edb9b9f96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b55686b893b48b0e1ad0193c980d0b0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6432 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-745 |
| filingDate |
2010-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3748cd8d7b251eabc31147bbb07dd91d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952325e66e8cc87c70f9aae6d5de8a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c76509d43dd3f6f722efffc04345a4c |
| publicationDate |
2011-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011012831-A1 |
| titleOfInvention |
Method for purifying active gla-domain coagulation proteins |
| abstract |
The invention relates to a method for purifying biologically active GLA-domain coagulation proteins, comprising the following steps: a) bringing a sample that contains one or more GLA-domain coagulation proteins and may contain biologically inactive molecules of GLA-domain protein(s), into contact with an affinity substrate on which nucleic aptamers that bind specifically to at least one biologically active GLA-domain coagulation protein are immobilized, in order to form complexes between (i) said nucleic aptamers and (ii) said GLA-domain coagulation protein(s), b) releasing the GLA-domain coagulation protein(s) from the complexes formed in step a), and c) recovering said biologically active GLA-domain coagulation protein(s) in a purified form. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017191424-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019150050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3050992-A1 |
| priorityDate |
2009-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |